Filter posts

Finding Value in Early Stage Collaborations at the BIO Technology Transfer Symposium

The BIO Technology Transfer Symposium dissects recent academia-industry collaborations and evaluates the value in early …

BIO Voices Agree: Intellectual Property Delivers

Over the last year, the U.S. Chamber of Commerce’s Global IP Center (GIPC) has met …

Novartis at India Supreme Court: Evergreening Myths and Patent Reality

Novartis will go before India’s Supreme Court on September 11, 2012 challenging the refusal by …

AMP v. Myriad: BIO Statement on Federal Circuit (Re)Decision

BIO released the following statement on the Federal Circuit’s decision in the AMP v. Myriad …

Technology Transfer Impact? Senator Bayh Informs on IPWatchdog

IPWatchdog published an article by former Senator Birch Bayh highlighting a BIO commissioned study showing …

USPTO Blogpost Brings Mayo Down to Earth

The United States Patent and Trademark Office Director David Kappos posted a blogpost called “Some …

The U.S. Government’s Position in ACLU v. Myriad Genetics

Hans Sauer, BIO’s Deputy General Counsel for Intellectual Property, comments on  the Department of Justice’s brief …

Patent Evergreening in India: Response from the Other Side

Thank you Adriana for commenting on my article Patent “Ever-Greening”: Novartis Confronts Patent Myth in …

Seed Patents: How Innovation May Get Lost in the Grain Elevator

The Bowman v. Monsanto case currently on petition for a writ of certiorari to the …

Gene Patent Discussion Should Include Industrial, Environmental, & Ag Biotech

Twenty-three industrial and agricultural biotech companies, ranging from development-stage businesses to all of the largest …